Yüklüyor......
The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma
LTX-401 is a novel oncolytic compound designed for the local treatment of solid tumors. In the present study, we have examined the applicability and efficacy of LTX-401 in a rat model JM1 hepatocellular carcinoma, with particular interest in its ability to induce antitumor immunity. LTX-401 induces...
Kaydedildi:
| Yayımlandı: | Mol Ther Oncolytics |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Gene & Cell Therapy
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562107/ https://ncbi.nlm.nih.gov/pubmed/31211244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2019.05.002 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|